Methods for Carbon Mass Closure in Polyolefin Hydrocracking by Anna E. Brenner (13906458)

Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

“…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d⁹ metalloradicals of the form [M(PR₃)₂]⁺ (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr^F₄]⁻ (Ar^F = 3,5-(CF₃)₂C₆H₃) counterion. …”

Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

“…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d⁹ metalloradicals of the form [M(PR₃)₂]⁺ (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr^F₄]⁻ (Ar^F = 3,5-(CF₃)₂C₆H₃) counterion. …”

Distribution of the ΔNPP-to-ΔMAT ratio in relation to MAT and MAP under the current climate. by Jumpei Toriyama (10156884)

“…<p>Results from (A) MIROC5 and (B) GFDL-CM3, based on the RCP2.6 scenario. …”

Systemic anti-FLT1 peptide improves skeletal muscle pathology in <i>mdx</i> mice. by Mayank Verma (314207)

The effect of p53 dosage on Kras-driven hematolymphopoietic tumorigenesis. by Özgün Le Roux (18271992)

Image_2_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

“…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”

Image_1_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

“…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”

Malformations of cardiac valves in <i>Drosophila.</i> by Christian Meyer (6035)

General observations after 1 week of treatment with HCPT hydrogel. by Hongwei Gu (374046)

Microscopic examination of confrontation zones between <i>C</i>. <i>rosea</i> 100C/1 strain and GTD pathogens. by Adrienn Geiger (13730524)

The effect of <i>P. speciosa</i> on the macroscopic appearance of the gastric mucosa in ethanol-induced gastric mucosal lesions in rats. by Rami Al Batran (587060)

Estimated salinity at telemetry locations/timepoints from 2011–2017. by Ryan Takeshita (3992990)

Immunohistochemical analysis of the expression of the BAX protein in the gastric mucosa of rats. by Rami Al Batran (587060)

The top 20 candidate drugs demonstrating the most significant sensitivity differences between high- and low-GSRS subjects. by Yu Zhang (12946)

Time course of risk difference with various parameters. by Kouki Uchinomiya (16350276)

Flow diagram of patient selection for the study. by Yusuke Fuchioka (22806178)

Immunohistochemical analysis of HSP70 expression in the gastric mucosa of rats. by Rami Al Batran (587060)

Transport and Transformation of PFASs in an Aqueous Film-Forming Foam-Impacted Fractured Rock Aquifer by Iain Alexander (21431686)

Transport and Transformation of PFASs in an Aqueous Film-Forming Foam-Impacted Fractured Rock Aquifer by Iain Alexander (21431686)